Molecular Pathology 2021
Tracking # 20-855705
Course overview
This course covers: how pharmacogenomics testing may be used in personalized medicine, how various molecular testing techniques are used in targeted therapies, examples of somatic variants acquired through mutagenesis or germline variants acquired paternally and how molecular testing detects these variants for use in targeted therapies in oncology and other conditions, the challenge in molecular testing for the detection of somatic or germline variants, how polymorphic genotypes of the CYP2D6 gene contribute to an individual's sensitivity, toxicity, and/or resistance to particular therapies, and the role of variant genotypes of genes in patient response to warfarin and clopidogrel therapy.
Subject areas
This course counts toward the state boards and subject areas below.